Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Asan Medical Center0 个研究点目标入组 122 人开始时间: 待定最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Among study subjects requiring gastro-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic angiography for medical purposes
•Pancreatic cancer should be in both 1 and 2, 3 or 4.
•The control group, which is not pancreatic cancer, should be in both 1 and 2, 5 or 6.
•?Be at least 19 years old
•?Receipt of consent for gastro-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic procedure prior to duodenal fluid inhalation patient
•?Biopsy proven pancreatic ductal adenocarcinoma (PDAC) with stage I-IV
•?Suspected pancreatic cancer on imaging and scheduled for endoscopic ultrasound-guided pancreatic biopsy patient
•?Patient with pancreatic cystic tumors or patient with pancreatitis (acute or chronic)
•?No pancreatic disease patient

•Pancreatic cancer and non-pancreatic cancer control groups must not meet all of the items 1 to 3 to be eligible for enrollment.
•?Hemodynamically unstable for endoscopy to be performed
•?If there is a large amount of ascites that is not controlled to perform endoscopy
•?If you have a coagulation disorder that cannot be corrected for endoscopy

发起方